Before you sell to, join or invest in Traws Pharma, Inc.
MentionFox check on Traws Pharma, Inc.: only 1 source on file so far (checked 6 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/traws-pharma-inc-form-d-000004
Check Traws Pharma, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Traws Pharma, Inc. filed a Form D with the Securities and Exchange Commission on 2026-11-05.
Traws Pharma, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 5, 2026. Traws Pharma, Inc. trades on Nasdaq as TRAW; it was formerly Onconova Therapeutics, Inc. Its industry group is Biotechnology. It names Iain Dukes (CEO & Director), Charles Parker (CFO), Jack Stover (Chair) (SEC Form D, November 5, 2026).
In its own words: “Targeting escape mutations in hematological cancers with first and best in class medicines.” (trawspharma.com, checked November 6, 2026)
Traws Pharma, Inc. raised on Nov 5. 125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Selling to Traws Pharma, Inc.? See who runs it and how to reach them, plus this week's 25 other newly funded companies.
Is this your company?
Sell to companies like Traws Pharma, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-11-05 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Traws Pharma, Inc.
Free to see. No signup.
More on the people and the money behind Traws Pharma, Inc., from the filings we hold.
Biotechnology raises by companies based in Pennsylvania, filed within 90 days of this one, largest first.
Get an email when Traws Pharma, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Traws Pharma, Inc. raises, hires or launches. No email unless you switch it on.
Watch Traws Pharma, Inc. →Get the full cited report on Traws Pharma, Inc.
What the filing shows about Traws Pharma, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Traws Pharma, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Traws Pharma, Inc.'s address as 12 Penns Trail, Newtown, PA 18940.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Traws Pharma, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Traws Pharma, Inc. is a registered filer with the SEC (CIK 1130598) and has filed since 2024-04-16. 2 filings are on record, the latest on 2026-11-05.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Traws Pharma, Inc.'s Form D of 2026-11-05 names Iain Dukes, Charles Parker, Jack Stover and 5 more as its officers, directors or promoters.
Its new offerings report $14M sold across 1 offering, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 763 filings in Biotechnology, totalled by week.
On the filing as: Executive Officer, Director.
Iain Dukes is named as Ceo & Director on the Form D that Traws Pharma, Inc. filed with the SEC on 5 November 2026, one of 8 people that filing names.
On the filing as: Executive Officer.
Charles Parker is named as Cfo on the Form D that Traws Pharma, Inc. filed with the SEC on 5 November 2026, one of 8 people that filing names.
On the filing as: Director.
Jack Stover is named as Chair on the Form D that Traws Pharma, Inc. filed with the SEC on 5 November 2026, one of 8 people that filing names.
Nikolay Savchuk is named as Director on the Form D that Traws Pharma, Inc. filed with the SEC on 5 November 2026, one of 8 people that filing names.
Trafford Clarke is named as Director on the Form D that Traws Pharma, Inc. filed with the SEC on 5 November 2026, one of 8 people that filing names.
Mary Shoemaker is named as Director on the Form D that Traws Pharma, Inc. filed with the SEC on 5 November 2026, one of 8 people that filing names.
John Leaman is named as Director on the Form D that Traws Pharma, Inc. filed with the SEC on 5 November 2026, one of 8 people that filing names.
Werner Cautreels is named as Director on the Form D that Traws Pharma, Inc. filed with the SEC on 5 November 2026, one of 8 people that filing names.
8 people named on the filing — 2 holding an executive role and 6 as directors only.
Named as of the 2026-11-05 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Traws Pharma, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Traws Pharma, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Traws Pharma, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Traws Pharma, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Traws Pharma, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Traws Pharma, Inc.. With no account yet, you sign up free and land on the result.
On these lists: The rest of the US raises, week of 2026-11-02 · Biotech raises, week of 2026-11-02
https://mentionfox.com/funding/traws-pharma-inc-form-d-000004